posted on 2016-12-16, 12:46authored byElizabeth Pisani, Stella Botchway
An in-depth case
study funded by the Wellcome Trust to capture the learning provided by the
Worldwide Antimalarial Resistance Network (WWARN) as a pioneering data platform
bringing together clinical, in-vitro, molecular, pharmacological and medicine
quality data relevant to the efficacy of anti-malarial medicines.